HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandra Silva Selected Research

Hepatitis

1/2017HPV16 induces a wasting syndrome in transgenic mice: Amelioration by dietary polyphenols via NF-κB inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandra Silva Research Topics

Disease

9Neoplasms (Cancer)
12/2022 - 01/2007
4Inflammation (Inflammations)
01/2018 - 01/2007
3Infections
06/2023 - 06/2010
3Chronic Renal Insufficiency
01/2021 - 01/2008
3Carcinogenesis
02/2018 - 01/2017
1COVID-19
06/2023
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2022
1Hyperparathyroidism
01/2021
1Primary Hyperparathyroidism
01/2021
1Skin Neoplasms (Skin Cancer)
01/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Pain (Aches)
09/2020
1Tendinopathy (Tendonitis)
09/2020
1Hepatitis
01/2017
1Cachexia
01/2017
1Wasting Syndrome (Wasting Disease)
01/2017
1Septic Shock (Toxic Shock Syndrome)
06/2016
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2015
1Cardiovascular Diseases (Cardiovascular Disease)
01/2015
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
05/2008
1Acute Kidney Injury (Acute Renal Failure)
01/2008
1Sepsis (Septicemia)
01/2008
1Uremia
01/2008
1Nephrotic Syndrome (Syndrome, Nephrotic)
10/2007
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
10/2007
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2007
1Bronchiolitis Obliterans Syndrome
10/2007
1Proteinuria
10/2007

Drug/Important Bio-Agent (IBA)

3MicroRNAs (MicroRNA)IBA
02/2018 - 01/2017
2Oleic Acid (Oleate)IBA
01/2021 - 01/2015
2Olive OilIBA
01/2021 - 01/2015
2Rutin (Rutoside)IBA
01/2018 - 01/2017
2CurcuminIBA
01/2018 - 01/2017
2PolyphenolsIBA
01/2017 - 06/2010
2HLA-DR Antigens (HLA-DR)IBA
01/2008 - 01/2008
1Immunoglobulin G (IgG)IBA
06/2023
1COVID-19 VaccinesIBA
06/2023
1BNT162 VaccineIBA
06/2023
1AntibodiesIBA
06/2023
1Immunoglobulin A (IgA)IBA
06/2023
1VaccinesIBA
06/2023
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
12/2022
1CalciumIBA
01/2021
13,4-dihydroxyphenylethanol (hydroxytyrosol)IBA
01/2021
1LipidsIBA
01/2019
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2018
1Celecoxib (Celebrex)FDA Link
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2015
1AD 5IBA
06/2010
1Antiviral Agents (Antivirals)IBA
06/2010
1ResveratrolIBA
06/2010
1Prednisolone (Predate)FDA LinkGeneric
10/2007
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
10/2007
1Immunosuppressive Agents (Immunosuppressants)IBA
10/2007
1Interleukin-6 (Interleukin 6)IBA
01/2007
1AntigensIBA
01/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2007

Therapy/Procedure

2Therapeutics
01/2021 - 01/2018
2Stem Cell Transplantation
06/2016 - 10/2007
1Parathyroidectomy
01/2021
1Massage (Zone Therapy)
09/2020
1Analgesia
09/2020
1Artificial Respiration (Mechanical Ventilation)
06/2016
1Condoms (Condom)
05/2008
1Intrauterine Devices (Intrauterine Device)
05/2008
1Transplantation
10/2007
1Aftercare (After-Treatment)
10/2007